Articles & Video
Andreas Diacon, TASK Applied Science, announced as winner of Christine Pierre Lifetime Achievement Award 2019
At this year's Clinical Trials Europe, the Christine Pierre Lifetime Achievement Award 2019 was presented to Andreas Diacon, Founder, Director and & CEO at TASK Applied Science.
Life Sciences in 2020: Predictions from industry insiders
Industry insiders predict how life sciences will change in 2020 in emerging therapies, clinical trials, regulations and agriculture.
Clinical Trials State of the Industry Report 2019
Clinical Trials State of the Industry 2019: Download the report offering insights into wearables, AI, virtual trials, partnerships and vendor oversight.
Clinical Trials Digital Week 2019 - 7 webinars on-demand
Register for Clinical Trials Digital Week 2019 for on-demand webinars and downloadable resources.
Low literacy issues and the Patient Information Leaflet
Former a senior research nurse Kate O’Brien looks at how low literacy levels in the UK present a challenge to effective Patient Information Leaflets for clinical trials.
Increasing research awareness and changing public perception of clinical trials
Site consultant Kate O’Brien looks at ways to increase research awareness to help boost patient engagement in clinical trials.
The Pain Clinic - Solving the five most common problems in clinical trials
Kate O’Brien examines the most common problems in all aspects of running clinical trials and the potential solutions to them.
The 10 most read posts of 2018
The 10 most read clinical trials posts of 2018 on data, patient-centricity, AI, partnerships and recruitment.
Forming clinical trial consortia is "definitely the future" - Dr. Raphaela Schnurbus
Dr. Raphaela Schnurbus, Clinical Solutions Director at CRO OPIS, discusses how partnerships in clinical trials are evolving and the challenges that still need to be overcome.
How a patient and doctors worked together to form innovative non-profit OurBrainBank
Jessica Morris tells the story of how she created the non-profit OurBrainBank after being diagnosed with glioblastoma (GBM) in 2016.
How full virtual clinical trials can become reality in the next 10 years
How can virtual clinical trials be implemented in the next 10 years through EHRs, synthetic biology and nanopores? Michelle Petersen takes a deep dive.
Why patient recruitment is the biggest challenge in clinical trials – INDUSTRY VOICES
Six clinical insiders offer their views on the challenge of patient recruitment in clinical trials and how they are dealing with it.
The potential of smart adherence tools in clinical trials
Dr Hilde Vanaken, Clinical Innovation Director at Janssen, explores the opportunities around smart adherence tools as well as the implementation barriers.
How clinical trials are going to change in the next five years – INDUSTRY VOICES
Four clinical experts predict how clinical trials are going to change in the coming years.
How patient-centricity can be achieved in clinical trials - INDUSTRY VOICES
We asked four clinical trial professionals to give their views regarding patient-centricity within the industry and the methods by which this can be achieved.
Beyond the hype of clinical trial innovation is a back room of nerds thinking about your product
How well will the clinical trials industry embrace innovative change? Gerald L. Messerschmidt, CMO at Precision for Medicine, explores.
The patient-centricity gap in clinical trials - data report analysis
We analyse the data from our recent clinical survey around the perceptions, implementation, benefits and challenges of patient-centricity in the clinical trials industry.
INDUSTRY REPORT: Beyond the Hype in Clinical Trials
Download our report based on 199 survey responses exploring the impact trends are having on clinical trials including mHealth, AI, patient-centricity and M&As.
6 ways clinical trials are changing
Anna Matranga from AMC Alliances & Consulting predicts six ways clinical trials will change in the next five to ten years.
What increased investment means for rare disease clinical trials
Dr Julie Vallortigara from Ataxia UK explores how pharma investment is tackling the challenges in the rare disease space and creating new partnership trends.